HiJAKing Immunotherapy-Resistant Melanoma for a Cure.

ABSTRACT: Immune checkpoint blockers (ICBs) have brought great promise to patients with advanced melanoma, a tumor type that was claimed largely incurable not long ago. However, therapeutic resistance to ICBs has limited their utility in the clinic. Here, we provide a commentary on recent research endeavors concerning ICB resistance in melanoma patients.

SUBMITTER: Shi LZ 

PROVIDER: S-EPMC10020808 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature